secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aardvark Therapeutics, Inc. (AARD)
CIK:        0001774857
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001193125-25-267402
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aardvark Therapeutics reviews ARD-101 and ARD-201 programs at investor webinar; no new data disclosed
--------------------------------------------------------------------------------

- Filed presentation lacks specific clinical results or financial figures.
- Webinar covered ARD-101 and ARD-201 programs and ObesityWeek 2025 presentations.
- Materiality is limited as filing is a procedural update without substantive new information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1774857/000119312525267402/0001193125-25-267402-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1774857/000119312525267402/ck0001774857-20251105.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-267402

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer